Â鶹´«Ã½ÊÓƵÍøÕ¾

XClose

Â鶹´«Ã½ÊÓƵÍøÕ¾ News

Home
Menu

'Game-changing’ Alzheimer’s drug lecenemab rejected by EU

29 July 2024

“This conservative approach means that patients and doctors eager to explore a proven effective drug are now denied access," explains Professor Bart De Strooper (Â鶹´«Ã½ÊÓƵÍøÕ¾ Queen Square Institute of Neurology).

, , , , ,